HCW Biologics annual operating margin
2020
2022
2023
2024
2025
HCW Biologics's operating margin was −24,270.74% for fiscal 2025.
View full HCW Biologics company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −24,270.74% | −23123.14 pp |
| 2024 | 2024-12-31 | −1,147.60% | −242.64 pp |
| 2023 | 2023-12-31 | −904.96% | −680.65 pp |
| 2022 | 2022-12-31 | −224.32% | −82.25 pp |
| 2020 | 2020-12-31 | −142.07% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −2,601.08% | +50285.60 pp |
| Q1 2026 | 2026-03-31 | 49.78% | +38861.27 pp |
| Q4 2025 | 2025-12-31 | −16,439.62% | −15643.70 pp |
| Q3 2025 | 2025-09-30 | −21,095.26% | −20231.20 pp |
| Q2 2025 | 2025-06-30 | −52,886.67% | −50440.86 pp |
| Q1 2025 | 2025-03-31 | −38,811.49% | −38146.40 pp |
| Q4 2024 | 2024-12-31 | −795.92% | +17.39 pp |
| Q3 2024 | 2024-09-30 | −864.06% | −268.83 pp |
| Q2 2024 | 2024-06-30 | −2,445.81% | −1721.59 pp |
| Q1 2024 | 2024-03-31 | −665.09% | +12133.82 pp |
| Q4 2023 | 2023-12-31 | −813.31% | −390.86 pp |
| Q3 2023 | 2023-09-30 | −595.23% | −373.03 pp |
| Q2 2023 | 2023-06-30 | −724.22% | +49.14 pp |
| Q1 2023 | 2023-03-31 | −12,798.92% | −12738.59 pp |
| Q4 2022 | 2022-12-31 | −422.45% | — |
| Q3 2022 | 2022-09-30 | −222.20% | — |
| Q2 2022 | 2022-06-30 | −773.36% | — |
| Q1 2022 | 2022-03-31 | −60.33% | — |
Across the available reported history, HCW Biologics's operating margin decreased from −1,147.60% to −24,270.74%, a change of −23123.14 percentage points. The latest reported quarter, Q2 2026, shows −2,601.08%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review HCW Biologics filings at SEC.gov ↗